Todas las investigaciones
Activo, no reclutandoOBSERVACIONAL

PROPEL - A Prospective Observational Patient Registry to Evaluate ENPP1 and ABCC6 Deficiency

This study, called PROPEL, is looking into two rare genetic conditions: ENPP1 Deficiency and an early-onset form of ABCC6 Deficiency. It's a long-term observational study, meaning researchers will collect information from people during their regular doctor's visits rather than testing new treatments. The goal is to build a clearer picture of how these diseases progress and impact individuals. They'll look at things like genetic details, blood tests, X-rays, and how people feel in their daily lives. By understanding these conditions better, scientists hope to learn more about their effects, from initial symptoms to how they change over time. This information is crucial for developing better ways to manage and treat these rare conditions in the future.

De un vistazo

Estado
Activo, no reclutando
Patrocinador
Inozyme Pharma
Objetivo de inscripción
54
Inicio
25 Jul 2024
Estimación de finalización
28 Ago 2026

¿De qué trata este estudio?

This study, called PROPEL, is designed to learn more about two very rare genetic conditions: ENPP1 Deficiency and an early-onset form of ABCC6 Deficiency. When we say 'genetic conditions,' it means they are caused by changes in a person's genes, which are the instructions inside our bodies. Both conditions can cause health problems affecting bones, blood vessels, and other parts of the body.

For people with ENPP1 Deficiency, especially babies, it can be very serious. In children, it can lead to a bone condition called rickets, which causes soft and weak bones. Adults might experience softened bones (osteomalacia), hearing problems, hardened arteries, and issues with their heart or brain. Early-onset ABCC6 Deficiency can look very similar to the severe form of ENPP1 Deficiency in babies and can also lead to problems with blood vessels in the brain.

This study is 'observational,' which means participants won't receive any new medications or treatments as part of the study. Instead, researchers will collect information during your regular doctor's appointments. They'll look at existing medical records, including results from blood tests, X-rays, and scans, as well as asking about your symptoms and how you're feeling. The aim is to understand how these conditions develop and change over time in real-life situations, helping doctors and scientists gain a complete picture of what it's like to live with these diseases.

Puntos clave

  • This study is about understanding rare genetic conditions: ENPP1 Deficiency and early-onset ABCC6 Deficiency.
  • It's an 'observational' study, meaning no new treatments or medicines are given.
  • Information will be collected from your existing medical records and routine doctor's visits.
  • Your participation helps doctors learn more about how these rare conditions affect people over time.
  • This knowledge is important for developing better ways to help patients in the future.

¿Quién puede ser elegible?

To be part of this study, you or your child must have one of these conditions and agree to share your medical information. This means you need to or your legal guardian needs to give written permission after fully understanding what the study involves. You also need to agree to let the study team look at your relevant medical records.

Specifically, you might be able to join if you have a confirmed genetic diagnosis of ENPP1 Deficiency with two faulty copies of the gene, or one faulty copy along with certain health problems like multiple fractures, low bone density, ongoing bone pain, early heart issues, rickets, or a specific spinal condition. If you have an early-onset form of ABCC6 Deficiency (and are under 18 years old) with two faulty copies of the gene, you could also be eligible. The genetic tests must have been done by an approved laboratory.

However, you cannot join if you are unable to give your consent or if you are already taking part in another specific clinical study called INZ-701. Researchers want to ensure that all participants can understand and agree to the study requirements.

¿Podría este estudio ser adecuado para ti?

Responde estas preguntas rápidas para ver si puedes ser elegible. Esto es solo una guía: el equipo de investigación toma la decisión final.

  1. Have you or your child been diagnosed with ENPP1 Deficiency or early-onset ABCC6 Deficiency by a specialist?
  2. Are you able to provide written consent to participate?
  3. Are you willing to let the study team access your relevant medical records?
  4. If you have ENPP1 Deficiency, do you have two faulty gene copies, or one faulty copy with specific symptoms (like multiple fractures or early heart problems)?
  5. If you have ABCC6 Deficiency, are you under 18 years old with two faulty gene copies?
  6. Are you NOT currently part of another clinical study called INZ-701?
Responde cada pregunta para ver tu resultado.

¿En qué consiste la participación?

If you decide to take part in this registry, it will involve two main periods: a Screening Period and an Observational Period. During the Screening Period, the study team will collect information about your past medical history and current health from your existing medical records when you first join.

After that, during the Observational Period, the study team will continue to gather information from your routine, standard-of-care doctor's visits. This means you won't have extra study appointments; the information will come from the tests and check-ups you already have as part of your usual care. This might include results from blood tests, X-rays or scans of your bones and blood vessels, and assessments of your general health and how well you can do daily activities. You might also be asked to share how you're feeling through questionnaires. There are no study medications or interventions; it's purely about collecting information over time during your regular medical care.

Riesgos y beneficios potenciales

Because this is an observational study, there are no new treatments or procedures involved, so the medical risks are very low. The main potential inconvenience might be the time taken to provide consent and for your medical records to be reviewed. The potential benefit is that by sharing your health information, you will be helping researchers gain a much deeper understanding of ENPP1 and ABCC6 Deficiencies. This knowledge is crucial for developing better ways to diagnose, manage, and potentially treat these conditions in the future, ultimately benefiting others. Remember, your participation is voluntary, and you have the right to withdraw from the study at any time without affecting your medical care.

Locations (14)

  • Ann and Robert H. Lurie Children's Hospital
    Código postal verificado
    Chicago, Estados Unidos
  • Boston Children's Hospital
    Código postal verificado
    Boston, Estados Unidos
  • Mayo Clinic
    Código postal verificado
    Rochester, United States
  • CLINILABS Drug Development Corp
    Código postal verificado
    Eatontown, United States
  • The Children's Hospital of Philadelphia (CHOP)
    Código postal verificado
    Filadelfia, Estados Unidos
  • CHU Sainte-Justine Research Centre
    Código postal verificado
    Montreal, Canadá
  • Universitätsklinikum Hamburg-Eppendorf
    Código postal verificado
    Hamburgo, Alemania
  • IRCCS San Raffaele Hospital - Main
    Código postal verificado
    Milan, Italy
  • The University of Tokyo Hospital
    Código postal verificado
    Tokyo, Japan
  • Royal Hospital Muscat
    Código postal verificado
    Muscat, Oman
  • EU Hub - VCTC
    Código postal verificado
    Barcelona, España
  • Hospital Sant Joan de Deu
    Código postal verificado
    Barcelona, España

Preguntas comunes

¿Qué es un 'estudio observacional'?

An observational study means doctors will collect information from your regular medical appointments and existing records. You won't receive any new treatments or procedures as part of the study.

Will I have to take any new medicines?

No, this study does not involve any new medicines or treatments. You will continue with your usual medical care.

¿Cuánto tiempo estaré en el estudio?

The study aims to follow participants over a period of time, collecting information from their ongoing, routine medical care to understand the conditions over time. The exact duration will depend on the study design.

Will my doctors change my treatment if I join?

No, your medical treatment will not change because you are in the study. Your doctors will continue to provide the best care for you based on your needs.

Will my personal data be kept private?

Yes, all your personal and medical information collected for the study will be handled with strict confidentiality, following ethical and legal guidelines.

Cómo obtener más información

Siempre hable con su médico de cabecera o especialista antes de decidir participar en un estudio.

Discusión

Discusión comunitaria

Impulsado por nuestro foro en community.patient.info. Por favor, sea respetuoso — esto no es un consejo médico.